Psychiatr Serv 51:527-529, April 2000
© 2000 American Psychiatric Association
Potential Cost Savings From Pill Splitting of Newer Psychotropic Medications
Carl I. Cohen, M.D. and
Sara I. Cohen
Many of the newer psychotropic medications have a pricing structure in which there are only small cost differences between pills of different strengths, affording an opportunity for cost saving by splitting pills. Twelve newer psychotropic medications were examined. Although savings varied for each drug, aggregate data indicated that splitting pills can produce an annual savings of up to $1.45 billion, which represents about 10 percent of the retail sales of these drugs. Such savings can benefit individuals, state Medicaid programs, community mental health centers, and managed care companies. The authors propose several strategies for encouraging the use of pill splitting.
This article has been cited by other articles:
|
|
|
|
 
E. M. Weissman and C. Dellenbaugh
Impact of Splitting Risperidone Tablets on Medication Adherence and on Clinical Outcomes for Patients With Schizophrenia
Psychiatr Serv,
February 1, 2007;
58(2):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Dobscha, T. A. Anderson, W. F. Hoffman, L. M. Winterbottom, E. H. Turner, L. S. Snodgrass, and P. Hauser
Strategies to Decrease Costs of Prescribing Selective Serotonin Reuptake Inhibitors at a VA Medical Center
Psychiatr Serv,
February 1, 2003;
54(2):
195 - 200.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
